This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Merck & Co., Inc.
Drug Names(s): hepatitis B vaccine (recombinant)
Description: Recombivax HB is a recombinant vaccine against infection with hepatitis B. It comes in adult, pediatric/adolescent, and dialysis formulations.
Recombivax HB News
Pink Sheet Recombivax HB
Pink Sheet Merck's Recombivax HB patent
Additional information available to subscribers only: